D.E. Shaw & Co’s Eli Lilly LLY Stock Holding History

D.E. Shaw & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$317M	Sell	345,000 -143,400	-29%	-$145M	0.19%	98
2025 Q4	$525M	Sell	488,400 -138,500	-22%	-$132M	0.29%	56
2025 Q3	$478M	Buy	626,900 +234,300	+60%	+$174M	0.27%	57
2025 Q2	$306M	Buy	392,600 +89,800	+30%	+$69.8M	0.22%	89
2025 Q1	$250M	Sell	302,800 -272,300	-47%	-$227M	0.22%	86
2024 Q4	$444M	Buy	575,100 +254,300	+79%	+$211M	0.33%	47
2024 Q3	$284M	Buy	320,800 +34,200	+12%	+$30.7M	0.24%	77
2024 Q2	$259M	Sell	286,600 -39,600	-12%	-$31.7M	0.24%	79
2024 Q1	$254M	Buy	326,200 +54,800	+20%	+$39M	0.22%	96
2023 Q4	$158M	Buy	271,400 +101,400	+60%	+$59.2M	0.14%	159
2023 Q3	$91.3M	Buy	170,000 +48,300	+40%	+$24.9M	0.1%	248
2023 Q2	$57.1M	Sell	121,700 -8,300	-6%	-$3.48M	0.06%	389
2023 Q1	$44.6M	Buy	130,000 +9,200	+8%	+$3.1M	0.05%	473
2022 Q4	$44.2M	Buy	120,800 +10,800	+10%	+$3.83M	0.05%	484
2022 Q3	$35.6M	Buy	+110,000	New	+$34.9M	0.04%	540
2022 Q1	–	Sell	-64,000	Closed	-$17.7M	–	5776
2021 Q4	$17.7M	Buy	64,000 +60,000	+1,500%	+$15.2M	0.01%	1175
2021 Q3	$924K	Hold	4,000	–	–	﹤0.01%	3667
2021 Q2	$918K	Buy	+4,000	New	+$803K	﹤0.01%	3610
2021 Q1	–	Sell	-20,600	Closed	-$3.48M	–	4297
2020 Q4	$3.48M	Hold	20,600	–	–	﹤0.01%	2147
2020 Q3	$3.05M	Sell	20,600 -15,500	-43%	-$2.4M	﹤0.01%	2057
2020 Q2	$5.93M	Hold	36,100	–	–	0.01%	1539
2020 Q1	$5.01M	Buy	36,100 +26,100	+261%	+$3.59M	0.01%	1462
2019 Q4	$1.31M	Sell	10,000 -50,000	-83%	-$5.8M	﹤0.01%	2790
2019 Q3	$6.71M	Buy	60,000 +50,000	+500%	+$5.57M	0.01%	1427
2019 Q2	$1.11M	Sell	10,000 -481,500	-98%	-$56.7M	﹤0.01%	2613
2019 Q1	$63.8M	Buy	491,500 +363,400	+284%	+$44.2M	0.08%	302
2018 Q4	$14.8M	Buy	128,100 +68,100	+114%	+$7.61M	0.02%	860
2018 Q3	$6.44M	Sell	60,000 -91,400	-60%	-$9.14M	0.01%	1408
2018 Q2	$12.9M	Sell	151,400 -6,500	-4%	-$534K	0.02%	941
2018 Q1	$12.2M	Buy	157,900 +112,900	+251%	+$9.09M	0.02%	893
2017 Q4	$3.8M	Hold	45,000	–	–	0.01%	1681
2017 Q3	$3.85M	Hold	45,000	–	–	0.01%	1574
2017 Q2	$3.7M	Sell	45,000 -105,000	-70%	-$8.57M	0.01%	1557
2017 Q1	$12.6M	Hold	150,000	–	–	0.02%	783
2016 Q4	$11M	Sell	150,000 -10,000	-6%	-$745K	0.02%	893
2016 Q3	$12.8M	Buy	+160,000	New	+$12.8M	0.02%	760
2016 Q1	–	Sell	-60,000	Closed	-$5.06M	–	3628
2015 Q4	$5.06M	Sell	60,000 -80,000	-57%	-$6.64M	0.01%	1393
2015 Q3	$11.7M	Buy	+140,000	New	+$11.8M	0.02%	874
2015 Q2	–	Sell	-30,000	Closed	-$2.18M	–	3809
2015 Q1	$2.18M	Sell	30,000 -299,000	-91%	-$21.3M	﹤0.01%	1943
2014 Q4	$22.7M	Buy	329,000 +30,000	+10%	+$2.02M	0.03%	660
2014 Q3	$19.4M	Sell	299,000 -50,000	-14%	-$3.17M	0.03%	712
2014 Q2	$21.7M	Buy	349,000 +99,000	+40%	+$5.91M	0.03%	652
2014 Q1	$14.7M	Buy	250,000 +100,000	+67%	+$5.58M	0.02%	819
2013 Q4	$7.65M	Sell	150,000 -49,200	-25%	-$2.46M	0.01%	1339
2013 Q3	$10M	Sell	199,200 -21,400	-10%	-$1.12M	0.02%	1008
2013 Q2	$10.8M	Buy	+220,600	New	+$12M	0.02%	821

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

D.E. Shaw & Co's LLY Position: Q1 2026 in Review

D.E. Shaw & Co increased its Eli Lilly (LLY) stake by 52% in Q1 2026, buying an estimated $221M and bringing the position to 637,382 shares worth $586M. The position accounts for 0.35% of the portfolio, ranked #39.

D.E. Shaw & Co first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. The position peaked at $958M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

D.E. Shaw & Co held 637,382 shares of Eli Lilly worth $586M as of Q1 2026.
D.E. Shaw & Co bought 218,331 Eli Lilly shares in Q1 2026, an estimated $221M.
Eli Lilly made up 0.35% of D.E. Shaw & Co's portfolio in Q1 2026, its #39 holding.
D.E. Shaw & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
D.E. Shaw & Co's Eli Lilly position peaked at $958M in Q4 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.